Company / Current Assets
AMICUS THERAPEUTICS, INC. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$676.2M
FY2025
5-year range
$423.8M / $676.2M
FY2021-FY2025
Trend
+34.0%
vs FY2024
Sector context
#85 of 213
Health Care
What the data says
At $676M, AMICUS THERAPEUTICS, INC.'s current assets ranks #85 of 213 in the Health Care sector. Current Assets has increased for 3 consecutive years, from $424M in FY2022 to $676M in FY2025.
Based on SEC 10-K filings.
$676M in FY2025 with a 5-year CAGR of +3.1%.
Improved from $483M to $676M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +16.8%
- 5-Year CAGR
- +3.1%
- 10-Year CAGR
- -
Sector benchmark
#85 of 213 in Health CareTop 40% of 213This company $676.2M Sector average $2.5B
▼
-73.2% below sector average
Key checks
Key Insights
- AMICUS THERAPEUTICS, INC.'s current assets has grown for 3 consecutive years.
- 5-year CAGR of +3.1%, indicating consistent growth.
- In FY2025, current assets increased 34.0% year-over-year.
- Ranks #85 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $676.2M | +34.0% |
| FY2024 | $504.7M | +4.5% |
| FY2023 | $483.1M | +14.0% |
| FY2022 | $423.8M | -29.0% |
| FY2021 | $596.8M | +3.0% |
| FY2020 | $579.5M | +11.4% |
| FY2019 | $520.1M | -5.6% |
| FY2018 | $551.1M | +40.6% |
| FY2017 | $392.0M | +15.3% |
| FY2016 | $340.1M | +57.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026